Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 636

Goldman Sachs helps sit $60m in Citixsys

The retail and hospitality management platform developer raised $60m in a Goldman Sachs-led round that took its total funding to at least $105m.

Nov 27, 2019

Corporates drop into Swat's series A

On-demand bus transportation service Swat secured $10.1m in a round backed by public transit operators SMRT and ComfortDelGro that will fund geographical expansion and recruitment.

Nov 27, 2019

Shuttl shoots to $36m for series C

The bus transportation provider's series C round currently stands at $36m, half of which has come from Toyota Tsusho and Mirai Creation Fund.

Nov 27, 2019

Loom loots $30m in series B round

The Slack-backed enterprise video messaging platform took its total funding to $45m with a Sequoia-led round that will fund product development.

Nov 27, 2019

NetEase tosses funding to Bossa

NetEase has led a series B round for the game developer reportedly sized at up to $30m and will now help it expand into China.

Nov 27, 2019

Heartseed to grow with series B funding

JMDC, Gene Techno Science, Astellas Venture Management and Nissay Capital have contributed to a $25.8m round for Keio University's heart failure treatment developer.

Nov 26, 2019

Daily deal net: November 26, 2019

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Nov 26, 2019

Advanced Navigation guides through $13.6m

University of Western Australia-founded automated navigation business Advanced Navigation will look to win custom in the US and Europe for its products, which operate in areas unreachable by GPS.

Nov 26, 2019

V2Food tucks into $23.8m series A

V2Food has secured series A funding on the back of its strategic partnership with burger retail chain Hungry Jack's.

Nov 26, 2019

FerGene secures $570m for first funding

FerGene has been spun off by Ferring Pharmaceuticals to bring a gene therapy for bladder cancer to market, and Ferring itself is supplying $170m of the cash.

Nov 26, 2019
© 2026 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here